Rendering

Component: (Network and Table)
Network
2315301 - Disclosure - Restructuring And Other Related Charges (Tables)
(http://www.danaher.com/role/RestructuringAndOtherRelatedChargesTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000313616 (http://www.sec.gov/CIK)
Restructuring and Related Activities [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Restructuring and Related Activities [Abstract]
 
Restructuring and Related Costs
Restructuring and other related charges recorded for the years ended December 31 by segment were as follows ($ in millions):
 
2016
 
2015
 
2014
Life Sciences
$
40.5

 
$
27.5

 
$
17.5

Diagnostics
62.2

 
33.6

 
32.6

Dental
34.3

 
25.3

 
21.4

Environmental & Applied Solutions
15.4

 
11.1

 
30.8

Total
$
152.4

 
$
97.5

 
$
102.3

The table below summarizes the Company’s accrual balance and utilization by type of restructuring cost associated with the 2016 and 2015 actions ($ in millions):
 
Employee Severance and Related
 
Facility Exit and Related
 
Total
Balance, January 1, 2015
$
73.9

 
$
13.0

 
$
86.9

Costs incurred
80.3

 
17.2

 
97.5

Paid/settled
(88.6
)
 
(16.3
)
 
(104.9
)
Balance, December 31, 2015
65.6

 
13.9

 
79.5

Costs incurred
111.0

 
41.4

 
152.4

Paid/settled
(131.3
)
 
(43.5
)
 
(174.8
)
Balance, December 31, 2016
$
45.3

 
$
11.8

 
$
57.1

  
Schedule of Restructuring Reserve by Type of Cost
These charges are reflected in the following captions in the accompanying Consolidated Statements of Earnings ($ in millions):
 
2016
 
2015
 
2014
Cost of sales
$
25.4

 
$
31.9

 
$
32.1

Selling, general and administrative expenses
127.0

 
65.6

 
70.2

Total
$
152.4

 
$
97.5

 
$
102.3